Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/26828
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Peverill R.E. | en |
dc.date.accessioned | 2021-05-14T08:56:54Z | en |
dc.date.available | 2021-05-14T08:56:54Z | en |
dc.date.copyright | 2005 | en |
dc.date.created | 20050207 | en |
dc.date.issued | 2012-10-17 | en |
dc.identifier.citation | Medical Journal of Australia. 182 (2) (pp 82-84), 2005. Date of Publication: 17 Jan 2005. | en |
dc.identifier.issn | 0025-729X | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/26828 | en |
dc.description.abstract | * Given fundamental differences in the recommendations in guidelines from major national and international committees, we cannot rely on them unquestioningly. * Different antihypertensive agents are known to have differing effects according to age and race. * Exchanging (rather than following guideline recommendations of adding to) an ineffective first-line antihypertensive drug can result in control of hypertension with monotherapy. * Conclusions about a preferable first-line antihypertensive agent are limited by trial protocols with varying drug doses and questionable drug combinations. * Guidelines are often based on meta-analyses of drugs of a particular class, which could ignore important differences between drugs within a class. * Trials of 3-5 years cannot determine the long-term effects of drugs which patients often take for decades. | en |
dc.language | English | en |
dc.language | en | en |
dc.publisher | Australasian Medical Publishing Co. Ltd | en |
dc.publisher | Australasian Medical Publishing Co. Ltd (Level 2, 26-32 Pyrmont Bridge Road, Pyrmont NSW 2009, Australia) | en |
dc.relation.ispartof | Medical Journal of Australia | en |
dc.title | Hypertension guidelines, meta-analyses and clinical trials: Do we assume too much?. | en |
dc.type | Review | en |
dc.type.studyortrial | Systematic review and/or meta-analysis | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.5694/j.1326-5377.2005.tb06582.x | en |
dc.publisher.place | Australia | en |
dc.identifier.pubmedid | 15651968 [http://www.ncbi.nlm.nih.gov/pubmed/?term=15651968] | en |
dc.identifier.source | 40147890 | en |
dc.identifier.institution | (Peverill) Centre for Heart and Chest Research, Monash University Dept. of Medicine, Monash Medical Centre, 246 Clayton Road, Clayton, Vic. 3168, Australia | en |
dc.description.address | R.E. Peverill, Cardiology Unit, Monash Medical Centre, 246 Clayton Road, Clayton, Vic. 3168, Australia. E-mail: roger.peverill@med.monash.edu.au | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2021 Elsevier B.V., All rights reserved. | en |
dc.rights.statement | Copyright 2012 Elsevier B.V., All rights reserved. | en |
dc.identifier.authoremail | Peverill R.E.; roger.peverill@med.monash.edu.au | en |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Review | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.